MAD0004J08: Clinical Trials

1 trial of MAD0004J08, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow MAD0004J08: new trials by email Literature Review of MAD0004J08 trials Research Report on MAD0004J08

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.
MAD0004J08, Placebo - Covid19
Phase 2 / Phase 3UnknownToscana Life Sciences Sviluppo s.r.l.8002021-06-062022-02-03

Conditions studied

COVID-19 (1)

Sponsors

Toscana Life Sciences Sviluppo s.r.l. (1)

Countries

Italy (1)

Top investigators

Simone Lanini (1)

Results publications

PMID 34473343